Third Australian report on antimicrobial use and resistance in human health
The Antimicrobial Use and Resistance in Australia (AURA) Surveillance system provides data and information to support Australia’s strategic response to one of the most significant challenges facing health care
around the world: antimicrobial resistance (AMR).
AMR reduces the range of antimicrobials available to treat infections, and increases morbidity and mortality associated with infections caused by multidrug-resistant organisms. AMR is well established as a priority for action due to its serious and growing impact on human health.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.